Close

Ratings by H.C. Wainwright (Boobalan Pachaiyappan)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/15/2024 PolyPid Ltd. PYPD Maintain Buy
(N/A)
 
 
  Details
2/5/2024 Hoth Therapeutics HOTH New Coverage Buy
(N/A)
1.29
(1.30)
0.78% Details
1/8/2024 Cingulate CING Maintain Buy
(N/A)
 
 
  Details
11/27/2023 Entrada Therapeutics TRDA Maintain Buy
(N/A)
 
 
  Details
10/12/2023 PolyPid Ltd. PYPD New Coverage Buy
(N/A)
4.00
(5.67)
41.75% Details
9/28/2023 Galecto GLTO Downgrade Neutral
(Buy)
0.70
(0.66)
-5.71% Details
9/26/2023 Cingulate CING Maintain Buy
(N/A)
 
 
  Details
9/25/2023 Ensysce Biosciences Inc. ENSC Maintain Buy
(N/A)
 
 
  Details
9/18/2023 Anebulo Pharmaceuticals ANEB New Coverage Buy
(N/A)
3.20
(2.85)
-10.94% Details
7/3/2023 Ensysce Biosciences Inc. ENSC New Coverage Buy
(N/A)
1.80
(0.89)
-50.56% Details
4/3/2023 Entrada Therapeutics TRDA New Coverage Buy
(N/A)
14.50
(13.35)
-7.93% Details